Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by Lemoyneon Feb 08, 2021 1:25pm
134 Views
Post# 32502383

RE:Cannabis sector.

RE:Cannabis sector.It's simple, while most cannabis stocks posted QoQ increases lately, LABS has posted QoQ abysmal decreases. Q3 was a YoY 80%+ decrease.

I don't understand people who expect this to rise 3-5x (what most cannabis stocks did lately) without any numbers to back it. You look at this objectively from a new investor point of view and currently compare the results of the past year with other mj stock and you would not touch this with a 1000m perch. Too much uncertainty even with 550k unit shipment news (explained in other posts).

This will undoubtedly take off, with current bull wave, if Q4 and Q1 show positive increase. Until then, IF you believe this can improve (not guaranteed), you can add, if not, you can short.
<< Previous
Bullboard Posts
Next >>